Atlas Trials

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Clinical trial NCT06993753 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06993753
Sponsor
Griffith University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Respiratory Syncytial Viral (RSV) Infections
Start date
2024-04-15
Primary completion
2026-04-15
Enrollment
4350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.